ATE521358T1 - Vorbeugender und/oder therapeutischer wirkstoff zur behandlung einer funktionellen gastrointestinalen erkrankung - Google Patents

Vorbeugender und/oder therapeutischer wirkstoff zur behandlung einer funktionellen gastrointestinalen erkrankung

Info

Publication number
ATE521358T1
ATE521358T1 AT08703370T AT08703370T ATE521358T1 AT E521358 T1 ATE521358 T1 AT E521358T1 AT 08703370 T AT08703370 T AT 08703370T AT 08703370 T AT08703370 T AT 08703370T AT E521358 T1 ATE521358 T1 AT E521358T1
Authority
AT
Austria
Prior art keywords
functional gastrointestinal
propionic acid
acid bacteria
preventive
bacteria fermentation
Prior art date
Application number
AT08703370T
Other languages
English (en)
Inventor
Masayuki Uchida
Shigeru Yamato
Hajime Ariga
Hirotsugu Uehara
Tomofumi Amano
Keiko Morikubo
Kaori Yoshida
Original Assignee
Meiji Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Meiji Co Ltd filed Critical Meiji Co Ltd
Application granted granted Critical
Publication of ATE521358T1 publication Critical patent/ATE521358T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/10—Laxatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nutrition Science (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AT08703370T 2007-01-17 2008-01-17 Vorbeugender und/oder therapeutischer wirkstoff zur behandlung einer funktionellen gastrointestinalen erkrankung ATE521358T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2007007628 2007-01-17
PCT/JP2008/050515 WO2008088008A1 (ja) 2007-01-17 2008-01-17 消化管機能異常症予防及び／又は治療剤

Publications (1)

Publication Number Publication Date
ATE521358T1 true ATE521358T1 (de) 2011-09-15

Family

ID=39636009

Family Applications (1)

Application Number Title Priority Date Filing Date
AT08703370T ATE521358T1 (de) 2007-01-17 2008-01-17 Vorbeugender und/oder therapeutischer wirkstoff zur behandlung einer funktionellen gastrointestinalen erkrankung

Country Status (9)

Country Link
US (1) US9675647B2 (de)
EP (1) EP2110133B1 (de)
JP (1) JPWO2008088008A1 (de)
KR (1) KR101459166B1 (de)
CN (1) CN101646444B (de)
AT (1) ATE521358T1 (de)
CA (1) CA2675729C (de)
ES (1) ES2367880T3 (de)
WO (1) WO2008088008A1 (de)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI476000B (zh) * 2009-12-10 2015-03-11 Meiji Co Ltd Production of Propionic Acid Bacteria in the Preparation of Preventive Agents for Influenza Infectious Diseases and Induction Promoters for Neutralizing Antibodies
US11179427B2 (en) 2013-01-21 2021-11-23 Eth Zurich Baby food composition comprising viable propionic acid-producing bacteria
WO2014163031A1 (ja) * 2013-04-01 2014-10-09 株式会社明治 即効性の整腸剤
WO2016183535A1 (en) 2015-05-14 2016-11-17 University Of Puerto Rico Methods for restoring microbiota of newborns
US11564667B2 (en) 2015-12-28 2023-01-31 New York University Device and method of restoring microbiota of newborns
WO2017164275A1 (ja) * 2016-03-24 2017-09-28 株式会社明治 口腔内環境改善用組成物
KR101923969B1 (ko) 2016-07-08 2018-11-30 주식회사 엠디헬스케어 프로피오니박테리움 속 세균 유래 나노소포 및 이의 용도
WO2018008895A1 (ko) 2016-07-08 2018-01-11 주식회사 엠디헬스케어 프로피오니박테리움 속 세균 유래 나노소포 및 이의 용도
WO2022124324A1 (ja) * 2020-12-09 2022-06-16 株式会社明治 アシディプロピオニバクテリウム属菌またはその処理物を含んでなる組成物
JPWO2023276702A1 (de) 2021-06-29 2023-01-05

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3315826B2 (ja) 1994-04-26 2002-08-19 明治乳業株式会社 ビフィズス菌増殖促進組成物
WO2001028547A1 (en) 1999-10-19 2001-04-26 Meiji Milk Products Co., Ltd Food materials useful in preventing and ameliorating metabolic bone diseases and preventives/remedies for metabolic bone diseases comprising these materials
US20040170617A1 (en) * 2000-06-05 2004-09-02 Finegold Sydney M. Method of treating diseases associated with abnormal gastrointestinal flora
US20030092163A1 (en) 2001-07-26 2003-05-15 Collins John Kevin Probiotic bifidobacterium strains
AU2002323899B2 (en) 2001-08-10 2007-06-28 Meiji Dairies Corporation Process for producing 1,4-dihydroxy -2-naphthoic acid
US20040005304A1 (en) * 2002-07-08 2004-01-08 Mak Wood, Inc. Novel compositions and methods for treating neurological disorders and associated gastrointestinal conditions
CA2549115C (en) * 2002-09-26 2013-07-16 Vita-Herb Nutriceuticals, Inc. Prebiotic and preservative uses of oil-emulsified probiotic encapsulations
US8871266B2 (en) * 2003-10-01 2014-10-28 Commonwealth Scientific & Industrial Research Organisation Probiotic storage and delivery
US8025911B2 (en) * 2004-04-13 2011-09-27 Meiji Dairies Corporation Preventive and/or remedy for inflammatory bowel diseases

Also Published As

Publication number Publication date
ES2367880T3 (es) 2011-11-10
WO2008088008A1 (ja) 2008-07-24
CA2675729C (en) 2015-05-12
US20100040698A1 (en) 2010-02-18
KR20090101961A (ko) 2009-09-29
CA2675729A1 (en) 2008-07-24
EP2110133A4 (de) 2010-05-19
EP2110133B1 (de) 2011-08-24
HK1140937A1 (en) 2010-10-29
CN101646444B (zh) 2013-11-06
JPWO2008088008A1 (ja) 2010-05-13
KR101459166B1 (ko) 2014-11-07
CN101646444A (zh) 2010-02-10
US9675647B2 (en) 2017-06-13
EP2110133A1 (de) 2009-10-21

Similar Documents

Publication Publication Date Title
JP7678786B2 (ja) ミトコンドリア機能向上と、神経変性疾患および認知障害治療とのための組成物および方法
EP2110133A4 (de) Vorbeugender und/oder therapeutischer wirkstoff für funktionelle dyspepsie
EP2440210A4 (de) Verfahren zur behandlung von magen-darm-erkrankungen
NO20092444L (no) Heteroarylamidderivater
EA201490512A1 (ru) Композиции, содержащие культивируемую в анаэробных условиях микробиоту кишечника человека
ATE449602T1 (de) Arzneimittel mit dobesilat-calcium zur behandlung und prophylaxe von sehnenerkrankungen
WO2011044506A3 (en) Sulphone compounds for use in the treatment of obesity
MX2013011835A (es) Composiciones nutricionales que incluyen acidos grasos de cadena ramificada para la curacion de heridas.
SG11201807500RA (en) Agent for increasing intestinal butyric acid and proliferation agent for butyric acid-producing bacteria
MX2014005433A (es) Métodos y composiciones para modular bacterias gastrointestinales para promover la salud.
SE1550189A1 (en) Therapeutic and prophylactic composition produced by microbiota
BR112014031730A2 (pt) entidades químicas, composições farmacêuticas, compostos ou sais farmaceuticamente aceitáveis dos mesmos, usos de entidades químicas ou composições e métodos para tratar doenças, distúrbios ou condições médicas mediadas pela atividade enzimática de pde1 e para modular a atividade da enzima pde1
PH12014500509B1 (en) Composition for use in the promotion of intestinal angiogenesis and of nutrient absorption and of enteral feeding tolerance and/or in the prevention and/or treatment of intestinal inflammation and/or in the recovery after intestinal injury and surgery
MX2009012197A (es) Metodos para tratamiento de ulceras en la piel.
EA201291441A1 (ru) Пробиотические штаммы для применения при улучшении состояния кишечной нервной системы
TN2011000482A1 (en) Organic compounds and their uses
MX2019002669A (es) Composicion farmaceutica para usarse en el tratamiento de la malnutricion en un sujeto que exhibe un trastorno de espectro de autismo (asd).
NO20091182L (no) 2-fenoksypyrimidinonanaloger
MX2022006407A (es) Composiciones bacterianas diseñadas y usos de estas.
EP4008786A3 (de) Mirna-212/132-familie als therapeutisches target
EA201200428A1 (ru) Композиция и способ для лечения ожирения
WO2007106909A3 (en) Method of using pomegranate extracts for increasing prostate specific antigen doubling time
JOP20190276B1 (ar) طرق وتركيبات لعلاج إسهال الحمض الصفراوي، والإسهال المرتبط باستئصال الأمعاء الدقيقة أو إزالة المرارة، ومتلازمة الأمعاء القصيرة
EA201400319A1 (ru) Продукты и способы
CN119769731A (zh) 支链脂肪酸组合物及其调节大脑神经免疫的用途

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties